A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA
β Scribed by SORBELLINI, MAXIMILIANO; KATTAN, MICHAEL W.; SNYDER, MARK E.; REUTER, VICTOR; MOTZER, ROBERT; GOETZL, MANLIO; McKIERNAN, JAMES; RUSSO, PAUL
- Book ID
- 123098961
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2005
- Tongue
- English
- Weight
- 83 KB
- Volume
- 173
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferonβalfa as firstβline therapy in patients with metastatic clearβcell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi
## Abstract ## BACKGROUND. The aim of the current study was to establish the predictive accuracy of the Kattan postoperative nomogram for nonmetastatic renal cell carcinoma (RCC) by comparing predictions with actual disease recurrence in patients who underwent surgery in a single center in France.